nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0883	0.236	CbGbCtD
Mianserin—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0557	0.149	CbGbCtD
Mianserin—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0445	0.119	CbGbCtD
Mianserin—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0378	0.101	CbGbCtD
Mianserin—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0292	0.0781	CbGbCtD
Mianserin—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0271	0.0726	CbGbCtD
Mianserin—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0253	0.0678	CbGbCtD
Mianserin—HTR1D—meninx—peripheral nervous system neoplasm	0.0218	0.114	CbGeAlD
Mianserin—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0218	0.0583	CbGbCtD
Mianserin—HTR1F—trigeminal nerve—peripheral nervous system neoplasm	0.0218	0.114	CbGeAlD
Mianserin—HTR1D—dura mater—peripheral nervous system neoplasm	0.0201	0.105	CbGeAlD
Mianserin—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0125	0.0333	CbGbCtD
Mianserin—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0122	0.0328	CbGbCtD
Mianserin—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.0117	0.0613	CbGeAlD
Mianserin—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0114	0.0305	CbGbCtD
Mianserin—HTR1D—trigeminal nerve—peripheral nervous system neoplasm	0.00864	0.0451	CbGeAlD
Mianserin—HTR1F—ganglion—peripheral nervous system neoplasm	0.00785	0.041	CbGeAlD
Mianserin—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00778	0.0208	CbGbCtD
Mianserin—HTR7—vagus nerve—peripheral nervous system neoplasm	0.00644	0.0336	CbGeAlD
Mianserin—HTR1D—cranial nerve—peripheral nervous system neoplasm	0.00615	0.0321	CbGeAlD
Mianserin—HTR6—ganglion—peripheral nervous system neoplasm	0.00534	0.0279	CbGeAlD
Mianserin—HTR7—cranial nerve—peripheral nervous system neoplasm	0.0049	0.0256	CbGeAlD
Mianserin—HTR7—pons—peripheral nervous system neoplasm	0.00484	0.0253	CbGeAlD
Mianserin—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00429	0.0224	CbGeAlD
Mianserin—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00401	0.021	CbGeAlD
Mianserin—SLC6A3—nerve—peripheral nervous system neoplasm	0.00323	0.0169	CbGeAlD
Mianserin—SLC6A3—ganglion—peripheral nervous system neoplasm	0.00319	0.0167	CbGeAlD
Mianserin—HTR1D—ganglion—peripheral nervous system neoplasm	0.00311	0.0163	CbGeAlD
Mianserin—HTR2C—ganglion—peripheral nervous system neoplasm	0.00308	0.0161	CbGeAlD
Mianserin—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00306	0.016	CbGeAlD
Mianserin—HTR2A—pons—peripheral nervous system neoplasm	0.00302	0.0158	CbGeAlD
Mianserin—SLC6A4—ganglion—peripheral nervous system neoplasm	0.00292	0.0153	CbGeAlD
Mianserin—Amitriptyline—NTRK2—peripheral nervous system neoplasm	0.00264	0.444	CrCbGaD
Mianserin—SLC6A2—nerve—peripheral nervous system neoplasm	0.00261	0.0136	CbGeAlD
Mianserin—HTR1A—ganglion—peripheral nervous system neoplasm	0.0026	0.0136	CbGeAlD
Mianserin—SLC6A2—ganglion—peripheral nervous system neoplasm	0.00257	0.0134	CbGeAlD
Mianserin—HTR7—nerve—peripheral nervous system neoplasm	0.00251	0.0131	CbGeAlD
Mianserin—HTR7—ganglion—peripheral nervous system neoplasm	0.00248	0.013	CbGeAlD
Mianserin—DRD2—nerve—peripheral nervous system neoplasm	0.00238	0.0124	CbGeAlD
Mianserin—DRD2—ganglion—peripheral nervous system neoplasm	0.00235	0.0123	CbGeAlD
Mianserin—Amitriptyline—NTRK1—peripheral nervous system neoplasm	0.00163	0.274	CrCbGaD
Mianserin—HTR2A—nerve—peripheral nervous system neoplasm	0.00157	0.00818	CbGeAlD
Mianserin—HTR2A—ganglion—peripheral nervous system neoplasm	0.00155	0.00808	CbGeAlD
Mianserin—HTR1D—trigeminal ganglion—peripheral nervous system neoplasm	0.00153	0.00799	CbGeAlD
Mianserin—SLC6A3—brainstem—peripheral nervous system neoplasm	0.00139	0.00724	CbGeAlD
Mianserin—HTR1D—brainstem—peripheral nervous system neoplasm	0.00135	0.00707	CbGeAlD
Mianserin—HTR2C—brainstem—peripheral nervous system neoplasm	0.00134	0.007	CbGeAlD
Mianserin—SLC6A4—brainstem—peripheral nervous system neoplasm	0.00127	0.00664	CbGeAlD
Mianserin—HTR1A—brainstem—peripheral nervous system neoplasm	0.00113	0.00589	CbGeAlD
Mianserin—ADRA2C—trigeminal ganglion—peripheral nervous system neoplasm	0.00112	0.00585	CbGeAlD
Mianserin—SLC6A2—brainstem—peripheral nervous system neoplasm	0.00112	0.00584	CbGeAlD
Mianserin—HTR7—brainstem—peripheral nervous system neoplasm	0.00108	0.00563	CbGeAlD
Mianserin—OPRK1—cerebellum—peripheral nervous system neoplasm	0.00106	0.00553	CbGeAlD
Mianserin—ADRA2C—parotid gland—peripheral nervous system neoplasm	0.00106	0.00552	CbGeAlD
Mianserin—DRD2—brainstem—peripheral nervous system neoplasm	0.00102	0.00533	CbGeAlD
Mianserin—HRH1—trigeminal ganglion—peripheral nervous system neoplasm	0.00091	0.00475	CbGeAlD
Mianserin—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.000894	0.00467	CbGeAlD
Mianserin—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.000728	0.00244	CcSEcCtD
Mianserin—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000726	0.00243	CcSEcCtD
Mianserin—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000726	0.00243	CcSEcCtD
Mianserin—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.000724	0.00242	CcSEcCtD
Mianserin—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.000724	0.00242	CcSEcCtD
Mianserin—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000723	0.00242	CcSEcCtD
Mianserin—Fatigue—Melphalan—peripheral nervous system neoplasm	0.000722	0.00241	CcSEcCtD
Mianserin—Eye disorder—Cisplatin—peripheral nervous system neoplasm	0.000721	0.00241	CcSEcCtD
Mianserin—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.000719	0.0024	CcSEcCtD
Mianserin—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.000716	0.00239	CcSEcCtD
Mianserin—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.000707	0.00236	CcSEcCtD
Mianserin—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000705	0.00236	CcSEcCtD
Mianserin—Anaemia—Vincristine—peripheral nervous system neoplasm	0.000702	0.00235	CcSEcCtD
Mianserin—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000699	0.00234	CcSEcCtD
Mianserin—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000699	0.00234	CcSEcCtD
Mianserin—Agitation—Vincristine—peripheral nervous system neoplasm	0.000698	0.00233	CcSEcCtD
Mianserin—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000695	0.00232	CcSEcCtD
Mianserin—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.000694	0.00232	CcSEcCtD
Mianserin—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.000693	0.00232	CcSEcCtD
Mianserin—SLC6A3—cerebellum—peripheral nervous system neoplasm	0.000684	0.00357	CbGeAlD
Mianserin—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000683	0.00228	CcSEcCtD
Mianserin—Vertigo—Vincristine—peripheral nervous system neoplasm	0.000682	0.00228	CcSEcCtD
Mianserin—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00068	0.00227	CcSEcCtD
Mianserin—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00068	0.00227	CcSEcCtD
Mianserin—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000679	0.00227	CcSEcCtD
Mianserin—HTR2A—brainstem—peripheral nervous system neoplasm	0.000673	0.00351	CbGeAlD
Mianserin—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.000671	0.00224	CcSEcCtD
Mianserin—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.000671	0.00224	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000666	0.00223	CcSEcCtD
Mianserin—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.00066	0.00221	CcSEcCtD
Mianserin—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000658	0.0022	CcSEcCtD
Mianserin—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000656	0.00219	CcSEcCtD
Mianserin—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.000656	0.00219	CcSEcCtD
Mianserin—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000656	0.00219	CcSEcCtD
Mianserin—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.000655	0.00219	CcSEcCtD
Mianserin—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000649	0.00217	CcSEcCtD
Mianserin—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000647	0.00216	CcSEcCtD
Mianserin—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000643	0.00215	CcSEcCtD
Mianserin—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.000641	0.00214	CcSEcCtD
Mianserin—Epinastine—ABCB1—peripheral nervous system neoplasm	0.000638	0.107	CrCbGaD
Mianserin—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.000637	0.00213	CcSEcCtD
Mianserin—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000633	0.00212	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000632	0.00211	CcSEcCtD
Mianserin—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000631	0.00211	CcSEcCtD
Mianserin—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00063	0.00211	CcSEcCtD
Mianserin—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000629	0.0021	CcSEcCtD
Mianserin—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000628	0.0021	CcSEcCtD
Mianserin—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000625	0.00209	CcSEcCtD
Mianserin—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000621	0.00207	CcSEcCtD
Mianserin—Oedema—Vincristine—peripheral nervous system neoplasm	0.00062	0.00207	CcSEcCtD
Mianserin—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000614	0.00205	CcSEcCtD
Mianserin—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000613	0.0032	CbGeAlD
Mianserin—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000609	0.00204	CcSEcCtD
Mianserin—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000609	0.00204	CcSEcCtD
Mianserin—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000608	0.00203	CcSEcCtD
Mianserin—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000607	0.00203	CcSEcCtD
Mianserin—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000606	0.00203	CcSEcCtD
Mianserin—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000605	0.00202	CcSEcCtD
Mianserin—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000601	0.00201	CcSEcCtD
Mianserin—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000601	0.00201	CcSEcCtD
Mianserin—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000601	0.00201	CcSEcCtD
Mianserin—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.0006	0.00201	CcSEcCtD
Mianserin—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.0006	0.00201	CcSEcCtD
Mianserin—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000598	0.002	CcSEcCtD
Mianserin—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000593	0.00198	CcSEcCtD
Mianserin—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.000587	0.00196	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000586	0.00196	CcSEcCtD
Mianserin—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000584	0.00195	CcSEcCtD
Mianserin—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000582	0.00195	CcSEcCtD
Mianserin—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000579	0.00194	CcSEcCtD
Mianserin—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000578	0.00193	CcSEcCtD
Mianserin—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.000573	0.00191	CcSEcCtD
Mianserin—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000572	0.00191	CcSEcCtD
Mianserin—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000572	0.00191	CcSEcCtD
Mianserin—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000572	0.00191	CcSEcCtD
Mianserin—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000569	0.0019	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000568	0.0019	CcSEcCtD
Mianserin—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000566	0.00189	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000565	0.00189	CcSEcCtD
Mianserin—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000561	0.00188	CcSEcCtD
Mianserin—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000561	0.00188	CcSEcCtD
Mianserin—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000557	0.00186	CcSEcCtD
Mianserin—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000556	0.00291	CbGeAlD
Mianserin—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000555	0.00186	CcSEcCtD
Mianserin—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000555	0.00185	CcSEcCtD
Mianserin—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000553	0.00185	CcSEcCtD
Mianserin—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000551	0.00184	CcSEcCtD
Mianserin—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00055	0.00184	CcSEcCtD
Mianserin—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000548	0.00183	CcSEcCtD
Mianserin—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000544	0.00182	CcSEcCtD
Mianserin—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000543	0.00181	CcSEcCtD
Mianserin—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000541	0.00181	CcSEcCtD
Mianserin—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000541	0.00181	CcSEcCtD
Mianserin—Rash—Topotecan—peripheral nervous system neoplasm	0.000539	0.0018	CcSEcCtD
Mianserin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000539	0.0018	CcSEcCtD
Mianserin—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000537	0.0018	CcSEcCtD
Mianserin—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000537	0.00179	CcSEcCtD
Mianserin—Headache—Topotecan—peripheral nervous system neoplasm	0.000536	0.00179	CcSEcCtD
Mianserin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000535	0.00179	CcSEcCtD
Mianserin—Rash—Tretinoin—peripheral nervous system neoplasm	0.000535	0.00179	CcSEcCtD
Mianserin—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000535	0.00179	CcSEcCtD
Mianserin—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000535	0.00179	CcSEcCtD
Mianserin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000535	0.00179	CcSEcCtD
Mianserin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000535	0.00179	CcSEcCtD
Mianserin—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000534	0.00179	CcSEcCtD
Mianserin—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000533	0.00178	CcSEcCtD
Mianserin—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000532	0.00178	CcSEcCtD
Mianserin—HTR7—cerebellum—peripheral nervous system neoplasm	0.000532	0.00278	CbGeAlD
Mianserin—Headache—Tretinoin—peripheral nervous system neoplasm	0.000532	0.00178	CcSEcCtD
Mianserin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000532	0.00178	CcSEcCtD
Mianserin—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000531	0.00178	CcSEcCtD
Mianserin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00053	0.00177	CcSEcCtD
Mianserin—Constipation—Vincristine—peripheral nervous system neoplasm	0.00053	0.00177	CcSEcCtD
Mianserin—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.00053	0.00177	CcSEcCtD
Mianserin—Rash—Melphalan—peripheral nervous system neoplasm	0.000528	0.00177	CcSEcCtD
Mianserin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000528	0.00176	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00052	0.00174	CcSEcCtD
Mianserin—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000517	0.00173	CcSEcCtD
Mianserin—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000512	0.00171	CcSEcCtD
Mianserin—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000506	0.00169	CcSEcCtD
Mianserin—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000504	0.00168	CcSEcCtD
Mianserin—DRD2—cerebellum—peripheral nervous system neoplasm	0.000503	0.00263	CbGeAlD
Mianserin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000499	0.00167	CcSEcCtD
Mianserin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000498	0.00166	CcSEcCtD
Mianserin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000492	0.00165	CcSEcCtD
Mianserin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000492	0.00164	CcSEcCtD
Mianserin—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00049	0.00164	CcSEcCtD
Mianserin—ADRA2C—cerebellum—peripheral nervous system neoplasm	0.000489	0.00255	CbGeAlD
Mianserin—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000488	0.00163	CcSEcCtD
Mianserin—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000479	0.0016	CcSEcCtD
Mianserin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000473	0.00158	CcSEcCtD
Mianserin—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.00047	0.00157	CcSEcCtD
Mianserin—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000469	0.00157	CcSEcCtD
Mianserin—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000463	0.00155	CcSEcCtD
Mianserin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000461	0.00154	CcSEcCtD
Mianserin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000455	0.00152	CcSEcCtD
Mianserin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000452	0.00151	CcSEcCtD
Mianserin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000451	0.00151	CcSEcCtD
Mianserin—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.00045	0.00151	CcSEcCtD
Mianserin—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000446	0.00149	CcSEcCtD
Mianserin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000445	0.00149	CcSEcCtD
Mianserin—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000441	0.00148	CcSEcCtD
Mianserin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000437	0.00146	CcSEcCtD
Mianserin—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000435	0.00145	CcSEcCtD
Mianserin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000433	0.00145	CcSEcCtD
Mianserin—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000433	0.00145	CcSEcCtD
Mianserin—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00043	0.00144	CcSEcCtD
Mianserin—Constipation—Etoposide—peripheral nervous system neoplasm	0.000429	0.00144	CcSEcCtD
Mianserin—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000428	0.00143	CcSEcCtD
Mianserin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000425	0.00142	CcSEcCtD
Mianserin—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000417	0.0014	CcSEcCtD
Mianserin—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000417	0.00139	CcSEcCtD
Mianserin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000414	0.00138	CcSEcCtD
Mianserin—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000412	0.00138	CcSEcCtD
Mianserin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00041	0.00137	CcSEcCtD
Mianserin—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000408	0.00136	CcSEcCtD
Mianserin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000406	0.00136	CcSEcCtD
Mianserin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000405	0.00135	CcSEcCtD
Mianserin—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000403	0.00135	CcSEcCtD
Mianserin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000403	0.00135	CcSEcCtD
Mianserin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000398	0.00133	CcSEcCtD
Mianserin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000396	0.00132	CcSEcCtD
Mianserin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000393	0.00131	CcSEcCtD
Mianserin—Rash—Vincristine—peripheral nervous system neoplasm	0.000391	0.00131	CcSEcCtD
Mianserin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00039	0.00131	CcSEcCtD
Mianserin—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.00039	0.00204	CbGeAlD
Mianserin—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000389	0.0013	CcSEcCtD
Mianserin—Headache—Vincristine—peripheral nervous system neoplasm	0.000388	0.0013	CcSEcCtD
Mianserin—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000386	0.00129	CcSEcCtD
Mianserin—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000381	0.00127	CcSEcCtD
Mianserin—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000373	0.00125	CcSEcCtD
Mianserin—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.00037	0.00124	CcSEcCtD
Mianserin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000369	0.00123	CcSEcCtD
Mianserin—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000368	0.00123	CcSEcCtD
Mianserin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000367	0.00123	CcSEcCtD
Mianserin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00036	0.0012	CcSEcCtD
Mianserin—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.00036	0.0012	CcSEcCtD
Mianserin—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000359	0.0012	CcSEcCtD
Mianserin—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000357	0.00119	CcSEcCtD
Mianserin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000355	0.00119	CcSEcCtD
Mianserin—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000347	0.00116	CcSEcCtD
Mianserin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000346	0.00116	CcSEcCtD
Mianserin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000345	0.00115	CcSEcCtD
Mianserin—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.00115	CcSEcCtD
Mianserin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.00114	CcSEcCtD
Mianserin—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.00034	0.00114	CcSEcCtD
Mianserin—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000333	0.00111	CcSEcCtD
Mianserin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000332	0.00111	CcSEcCtD
Mianserin—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000332	0.00173	CbGeAlD
Mianserin—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.0011	CcSEcCtD
Mianserin—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.00107	CcSEcCtD
Mianserin—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000319	0.00107	CcSEcCtD
Mianserin—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000317	0.00106	CcSEcCtD
Mianserin—Rash—Etoposide—peripheral nervous system neoplasm	0.000317	0.00106	CcSEcCtD
Mianserin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000316	0.00106	CcSEcCtD
Mianserin—Headache—Etoposide—peripheral nervous system neoplasm	0.000315	0.00105	CcSEcCtD
Mianserin—Trimipramine—ABCB1—peripheral nervous system neoplasm	0.000311	0.0521	CrCbGaD
Mianserin—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00031	0.00104	CcSEcCtD
Mianserin—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000309	0.00103	CcSEcCtD
Mianserin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000309	0.00103	CcSEcCtD
Mianserin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000303	0.00101	CcSEcCtD
Mianserin—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000302	0.00158	CbGeAlD
Mianserin—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000299	0.000999	CcSEcCtD
Mianserin—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000995	CcSEcCtD
Mianserin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000986	CcSEcCtD
Mianserin—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000294	0.000981	CcSEcCtD
Mianserin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000294	0.000981	CcSEcCtD
Mianserin—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.00098	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000292	0.000975	CcSEcCtD
Mianserin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000287	0.00096	CcSEcCtD
Mianserin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000958	CcSEcCtD
Mianserin—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000957	CcSEcCtD
Mianserin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000955	CcSEcCtD
Mianserin—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000284	0.000949	CcSEcCtD
Mianserin—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000941	CcSEcCtD
Mianserin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.000938	CcSEcCtD
Mianserin—Shock—Epirubicin—peripheral nervous system neoplasm	0.000277	0.000926	CcSEcCtD
Mianserin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000924	CcSEcCtD
Mianserin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000923	CcSEcCtD
Mianserin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000921	CcSEcCtD
Mianserin—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000921	CcSEcCtD
Mianserin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000275	0.000918	CcSEcCtD
Mianserin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000273	0.000914	CcSEcCtD
Mianserin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.000908	CcSEcCtD
Mianserin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.000908	CcSEcCtD
Mianserin—Desipramine—ABCB1—peripheral nervous system neoplasm	0.000272	0.0456	CrCbGaD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.000902	CcSEcCtD
Mianserin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.000888	CcSEcCtD
Mianserin—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000879	CcSEcCtD
Mianserin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000878	CcSEcCtD
Mianserin—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000871	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000857	CcSEcCtD
Mianserin—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000857	CcSEcCtD
Mianserin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000854	CcSEcCtD
Mianserin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000852	CcSEcCtD
Mianserin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.00085	CcSEcCtD
Mianserin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000846	CcSEcCtD
Mianserin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000845	CcSEcCtD
Mianserin—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00025	0.000836	CcSEcCtD
Mianserin—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000813	CcSEcCtD
Mianserin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000812	CcSEcCtD
Mianserin—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000811	CcSEcCtD
Mianserin—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000805	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000793	CcSEcCtD
Mianserin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000782	CcSEcCtD
Mianserin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000775	CcSEcCtD
Mianserin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.000774	CcSEcCtD
Mianserin—Imipramine—ABCB1—peripheral nervous system neoplasm	0.00023	0.0387	CrCbGaD
Mianserin—Amitriptyline—ABCB1—peripheral nervous system neoplasm	0.000229	0.0384	CrCbGaD
Mianserin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000752	CcSEcCtD
Mianserin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000751	CcSEcCtD
Mianserin—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000744	CcSEcCtD
Mianserin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000717	CcSEcCtD
Mianserin—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000675	CcSEcCtD
Mianserin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000666	CcSEcCtD
Mianserin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000625	CcSEcCtD
Mianserin—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000622	CcSEcCtD
Mianserin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000616	CcSEcCtD
Mianserin—Rash—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000593	CcSEcCtD
Mianserin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000593	CcSEcCtD
Mianserin—Headache—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000589	CcSEcCtD
Mianserin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000576	CcSEcCtD
Mianserin—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000549	CcSEcCtD
Mianserin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000548	CcSEcCtD
Mianserin—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000545	CcSEcCtD
Mianserin—ADRA2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.6e-05	0.0002	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.59e-05	0.0002	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	2.56e-05	0.000197	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.55e-05	0.000196	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.54e-05	0.000196	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.52e-05	0.000194	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.51e-05	0.000193	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.5e-05	0.000192	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.48e-05	0.000191	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.47e-05	0.00019	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	2.45e-05	0.000189	CbGpPWpGaD
Mianserin—ADRA2B—Hemostasis—TP53—peripheral nervous system neoplasm	2.45e-05	0.000189	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.43e-05	0.000187	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—NRAS—peripheral nervous system neoplasm	2.43e-05	0.000187	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.43e-05	0.000187	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.43e-05	0.000187	CbGpPWpGaD
Mianserin—HTR1F—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.4e-05	0.000185	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.4e-05	0.000185	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.4e-05	0.000185	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.4e-05	0.000184	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.39e-05	0.000184	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.38e-05	0.000183	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.38e-05	0.000183	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	2.37e-05	0.000182	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.36e-05	0.000182	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	2.36e-05	0.000182	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—GNAS—peripheral nervous system neoplasm	2.36e-05	0.000182	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.36e-05	0.000181	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.36e-05	0.000181	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.35e-05	0.000181	CbGpPWpGaD
Mianserin—ADRA2B—Hemostasis—HRAS—peripheral nervous system neoplasm	2.34e-05	0.00018	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.34e-05	0.00018	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.32e-05	0.000179	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—ABCB1—peripheral nervous system neoplasm	2.31e-05	0.000178	CbGpPWpGaD
Mianserin—ADRA2C—Hemostasis—TP53—peripheral nervous system neoplasm	2.29e-05	0.000176	CbGpPWpGaD
Mianserin—HRH2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.29e-05	0.000176	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.26e-05	0.000174	CbGpPWpGaD
Mianserin—HRH2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.22e-05	0.000171	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.22e-05	0.000171	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	2.21e-05	0.00017	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.2e-05	0.00017	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.2e-05	0.00017	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.2e-05	0.000169	CbGpPWpGaD
Mianserin—ADRA2C—Hemostasis—HRAS—peripheral nervous system neoplasm	2.19e-05	0.000169	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.19e-05	0.000168	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	2.17e-05	0.000167	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.17e-05	0.000167	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.16e-05	0.000167	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.15e-05	0.000166	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.15e-05	0.000165	CbGpPWpGaD
Mianserin—ADRA2B—Hemostasis—AKT1—peripheral nervous system neoplasm	2.07e-05	0.000159	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.05e-05	0.000158	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.04e-05	0.000157	CbGpPWpGaD
Mianserin—HRH2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.02e-05	0.000155	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	2.01e-05	0.000155	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	2e-05	0.000154	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2e-05	0.000154	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.97e-05	0.000152	CbGpPWpGaD
Mianserin—ADRA2C—Hemostasis—AKT1—peripheral nervous system neoplasm	1.93e-05	0.000149	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.91e-05	0.000147	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.89e-05	0.000145	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	1.88e-05	0.000145	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.86e-05	0.000143	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.86e-05	0.000143	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	1.86e-05	0.000143	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.85e-05	0.000142	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.85e-05	0.000142	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.84e-05	0.000142	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.82e-05	0.00014	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.81e-05	0.000139	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.78e-05	0.000137	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	1.78e-05	0.000137	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.78e-05	0.000137	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.77e-05	0.000136	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.75e-05	0.000135	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.75e-05	0.000135	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.74e-05	0.000134	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.74e-05	0.000134	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.74e-05	0.000134	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.73e-05	0.000134	CbGpPWpGaD
Mianserin—OPRK1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.73e-05	0.000133	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.72e-05	0.000132	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.72e-05	0.000132	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.71e-05	0.000132	CbGpPWpGaD
Mianserin—HTR6—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.71e-05	0.000131	CbGpPWpGaD
Mianserin—HTR7—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.7e-05	0.000131	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.7e-05	0.000131	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.7e-05	0.000131	CbGpPWpGaD
Mianserin—HTR1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.69e-05	0.00013	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.69e-05	0.00013	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.69e-05	0.00013	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.69e-05	0.00013	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.68e-05	0.000129	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.68e-05	0.000129	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.62e-05	0.000125	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.61e-05	0.000124	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.6e-05	0.000123	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	1.59e-05	0.000123	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.58e-05	0.000122	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.57e-05	0.000121	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	1.57e-05	0.000121	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.56e-05	0.00012	CbGpPWpGaD
Mianserin—HTR2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.56e-05	0.00012	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.55e-05	0.000119	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.55e-05	0.000119	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.55e-05	0.000119	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.54e-05	0.000119	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.54e-05	0.000118	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.54e-05	0.000118	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	1.54e-05	0.000118	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.53e-05	0.000118	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.53e-05	0.000118	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.53e-05	0.000118	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.51e-05	0.000116	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.51e-05	0.000116	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.5e-05	0.000116	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.49e-05	0.000115	CbGpPWpGaD
Mianserin—DRD3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.45e-05	0.000112	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.44e-05	0.000111	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.44e-05	0.00011	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.43e-05	0.00011	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.42e-05	0.000109	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.42e-05	0.000109	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.41e-05	0.000109	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.41e-05	0.000109	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.41e-05	0.000109	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.41e-05	0.000108	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.4e-05	0.000107	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.38e-05	0.000106	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.37e-05	0.000106	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.37e-05	0.000106	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.35e-05	0.000104	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.35e-05	0.000104	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.34e-05	0.000103	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.33e-05	0.000103	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.32e-05	0.000102	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.32e-05	0.000101	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.32e-05	0.000101	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.31e-05	0.000101	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.31e-05	0.000101	CbGpPWpGaD
Mianserin—ADRA2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.31e-05	0.000101	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.3e-05	0.0001	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.3e-05	0.0001	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.3e-05	9.98e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.29e-05	9.95e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.29e-05	9.94e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.28e-05	9.84e-05	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.26e-05	9.72e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.26e-05	9.67e-05	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.26e-05	9.67e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.25e-05	9.63e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.25e-05	9.61e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.24e-05	9.58e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.23e-05	9.48e-05	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.22e-05	9.41e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.21e-05	9.32e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.21e-05	9.32e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.2e-05	9.27e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.2e-05	9.26e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.19e-05	9.18e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.19e-05	9.17e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.19e-05	9.15e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.19e-05	9.14e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.15e-05	8.83e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.14e-05	8.78e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.14e-05	8.78e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.12e-05	8.64e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.12e-05	8.63e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.12e-05	8.62e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.11e-05	8.54e-05	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.11e-05	8.53e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.1e-05	8.46e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.1e-05	8.46e-05	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.09e-05	8.4e-05	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.09e-05	8.38e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.09e-05	8.36e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.08e-05	8.34e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.08e-05	8.34e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.08e-05	8.33e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.08e-05	8.32e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.08e-05	8.3e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.08e-05	8.28e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.05e-05	8.09e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.05e-05	8.07e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.04e-05	8.03e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.04e-05	7.98e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.04e-05	7.97e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.03e-05	7.92e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.02e-05	7.86e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.01e-05	7.81e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.01e-05	7.79e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.01e-05	7.75e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1e-05	7.74e-05	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.92e-06	7.64e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.91e-06	7.63e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.89e-06	7.61e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.88e-06	7.61e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	9.86e-06	7.59e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.83e-06	7.57e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.77e-06	7.52e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.72e-06	7.48e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.46e-06	7.28e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.45e-06	7.28e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.28e-06	7.15e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.21e-06	7.09e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.2e-06	7.08e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.15e-06	7.04e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.14e-06	7.04e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.08e-06	6.99e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.06e-06	6.97e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.04e-06	6.96e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.01e-06	6.94e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.8e-06	6.78e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.58e-06	6.6e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.44e-06	6.5e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.42e-06	6.48e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.35e-06	6.43e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.31e-06	6.4e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.24e-06	6.34e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.02e-06	6.17e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.98e-06	6.14e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.95e-06	6.12e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—AKT1—peripheral nervous system neoplasm	7.84e-06	6.03e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.77e-06	5.98e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.76e-06	5.97e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.68e-06	5.91e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.67e-06	5.91e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.63e-06	5.87e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.42e-06	5.71e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.04e-06	5.42e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.02e-06	5.4e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.93e-06	5.33e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.91e-06	5.32e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.77e-06	5.21e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.74e-06	5.19e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.74e-06	5.18e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.63e-06	5.1e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.61e-06	5.09e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.55e-06	5.05e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	6.37e-06	4.9e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.3e-06	4.85e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.03e-06	4.64e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	5.97e-06	4.59e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.95e-06	4.58e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.85e-06	4.5e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.84e-06	4.49e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.32e-06	4.1e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	4.15e-06	3.19e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	3.51e-06	2.71e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	2.71e-06	2.09e-05	CbGpPWpGaD
